Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CM-24 by Purple Biotech for Melanoma: Likelihood of Approval
CM-24 is under clinical development by Purple Biotech and currently in Phase I for Melanoma. According to GlobalData, Phase I...
CM-24 by Purple Biotech for Colorectal Cancer: Likelihood of Approval
CM-24 is under clinical development by Purple Biotech and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
CM-24 by Purple Biotech for Non-Small Cell Lung Cancer: Likelihood of Approval
CM-24 is under clinical development by Purple Biotech and currently in Phase I for Non-Small Cell Lung Cancer. According to...
CM-24 by Purple Biotech for Ovarian Cancer: Likelihood of Approval
CM-24 is under clinical development by Purple Biotech and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...